US Stock MarketDetailed Quotes

MED Medifast

Watchlist
  • 26.690
  • +0.760+2.93%
Close May 3 16:00 ET
  • 27.500
  • +0.810+3.03%
Post 16:37 ET
291.92MMarket Cap4.31P/E (TTM)

Medifast Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-88.63%7.28M
-24.11%147.66M
-79.66%10.52M
-45.97%29.93M
-1.41%43.15M
46.68%64.06M
105.80%194.57M
793.65%51.74M
250.61%55.4M
109.61%43.76M
Net income from continuing operations
-79.19%8.32M
-30.75%99.42M
-77.24%6.04M
-36.02%23.13M
-22.58%30.28M
-4.34%39.97M
-12.48%143.57M
-22.06%26.52M
-13.88%36.16M
-16.72%39.11M
Operating gains losses
--4K
-44.98%1.17M
--550K
--3K
----
----
106,400.00%2.13M
----
----
----
Depreciation and amortization
9.65%3.26M
19.37%13.11M
13.51%3.35M
19.72%3.41M
23.28%3.37M
21.69%2.97M
61.19%10.98M
-2.99%2.95M
116.89%2.85M
105.57%2.73M
Deferred tax
-86.00%112K
231.06%1.21M
716.06%6.71M
-260.65%-6.3M
--0
--800K
75.13%-924K
122.13%822K
---1.75M
--0
Other non cash items
-19.07%1.11M
-24.45%4.61M
-20.84%1.08M
-33.42%1.02M
-28.08%1.15M
-15.44%1.37M
20.30%6.1M
-13.00%1.36M
15.75%1.53M
22.65%1.59M
Change In working capital
-127.60%-5.06M
-6.35%20.28M
-161.79%-9.27M
-56.12%5.99M
305.27%5.22M
511.53%18.34M
124.70%21.65M
132.85%15.01M
143.86%13.64M
91.76%-2.54M
-Change in inventory
-62.12%8.32M
5.03%64.27M
-86.24%3.64M
-8.77%10.67M
-12.49%28M
345.94%21.96M
148.31%61.19M
152.40%26.42M
134.58%11.7M
195.36%32M
-Change in prepaid assets
-111.31%-742K
5,639.18%5.57M
-32.87%-2.38M
86.62%4.23M
18.40%-2.84M
111.23%6.56M
100.98%97K
62.61%-1.79M
618.31%2.27M
20.68%-3.48M
-Change in payables and accrued expense
-36.24%-12.66M
5.02%-35.71M
91.61%-1.35M
-10,728.33%-6.38M
36.71%-18.68M
-216.22%-9.29M
-169.13%-37.59M
-238.66%-16.13M
-98.96%60K
-480.43%-29.52M
-Change in other current assets
102.71%24K
-37.57%-4.69M
-100.39%-20K
-573.40%-2.53M
18.35%-1.26M
86.63%-887K
24.90%-3.41M
546.35%5.13M
85.71%-376K
-122.11%-1.54M
-Change in other working capital
----
-766.79%-9.16M
----
----
----
----
245.29%1.37M
----
----
----
Cash from discontinued investing activities
Operating cash flow
-88.63%7.28M
-24.11%147.66M
-79.66%10.52M
-45.97%29.93M
-1.41%43.15M
46.68%64.06M
105.80%194.57M
793.65%51.74M
250.61%55.4M
109.61%43.76M
Investing cash flow
Cash flow from continuing investing activities
-31.21%-2.78M
-434.84%-61.05M
-18.39%-10.73M
-2,527.66%-46.46M
-247.55%-1.74M
-19.90%-2.12M
60.73%-11.41M
22.02%-9.06M
82.98%-1.77M
119.15%1.18M
Net PPE purchase and sale
12.96%-1.84M
61.14%-6.48M
89.56%-946K
5.09%-1.68M
38.59%-1.74M
29.71%-2.12M
51.24%-16.68M
22.02%-9.06M
82.98%-1.77M
62.62%-2.84M
Net investment purchase and sale
---934K
-1,135.96%-54.56M
---9.79M
---44.78M
--0
--0
2.37%5.27M
--0
--0
182.25%4.02M
Cash from discontinued investing activities
Investing cash flow
-31.21%-2.78M
-434.84%-61.05M
-18.39%-10.73M
-2,527.66%-46.46M
-247.55%-1.74M
-19.90%-2.12M
60.73%-11.41M
22.02%-9.06M
82.98%-1.77M
119.15%1.18M
Financing cash flow
Cash flow from continuing financing activities
94.24%-1.49M
60.02%-79.79M
26.41%-17.91M
59.75%-18.15M
82.52%-17.84M
7.91%-25.9M
-59.50%-199.58M
22.10%-24.33M
-5.03%-45.11M
-255.02%-102.03M
Net common stock issuance
88.05%-817K
94.56%-6.96M
99.84%-10K
-340.00%-110K
100.00%-2K
40.33%-6.84M
-106.10%-127.96M
54.93%-6.41M
99.90%-25K
-798.07%-110.07M
Cash dividends paid
96.29%-710K
-1.95%-73.02M
-0.31%-17.98M
0.21%-18.04M
5.93%-17.83M
-15.02%-19.16M
-12.16%-71.62M
-5.36%-17.92M
-7.95%-18.08M
-13.49%-18.96M
Proceeds from stock option exercised by employees
-65.71%36K
--188K
--83K
--0
--0
--105K
--0
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
94.24%-1.49M
60.02%-79.79M
26.41%-17.91M
59.75%-18.15M
82.52%-17.84M
7.91%-25.9M
-59.50%-199.58M
22.10%-24.33M
-5.03%-45.11M
-255.02%-102.03M
Net cash flow
Beginning cash position
7.70%94.44M
-15.83%87.69M
61.74%112.75M
141.37%147.41M
4.87%123.75M
-15.83%87.69M
-36.37%104.18M
-54.88%69.71M
-68.19%61.07M
-42.73%118M
Current changes in cash
-91.63%3.02M
141.53%6.82M
-198.75%-18.11M
-506.95%-34.68M
141.29%23.57M
161.41%36.05M
72.47%-16.43M
136.46%18.34M
122.70%8.52M
-306.76%-57.08M
Effect of exchange rate changes
66.67%15K
-7.46%-72K
45.73%-197K
-78.15%26K
-38.78%90K
-70.00%9K
-159.82%-67K
-1,916.67%-363K
88.89%119K
1,436.36%147K
End cash Position
-21.23%97.47M
7.70%94.44M
7.70%94.44M
61.74%112.75M
141.37%147.41M
4.87%123.75M
-15.83%87.69M
-15.83%87.69M
-54.88%69.71M
-68.19%61.07M
Free cash flow
-91.22%5.44M
-20.64%141.17M
-77.56%9.58M
-47.32%28.25M
1.17%41.4M
52.33%61.94M
194.83%177.89M
323.63%42.68M
891.09%53.63M
208.15%40.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -88.63%7.28M-24.11%147.66M-79.66%10.52M-45.97%29.93M-1.41%43.15M46.68%64.06M105.80%194.57M793.65%51.74M250.61%55.4M109.61%43.76M
Net income from continuing operations -79.19%8.32M-30.75%99.42M-77.24%6.04M-36.02%23.13M-22.58%30.28M-4.34%39.97M-12.48%143.57M-22.06%26.52M-13.88%36.16M-16.72%39.11M
Operating gains losses --4K-44.98%1.17M--550K--3K--------106,400.00%2.13M------------
Depreciation and amortization 9.65%3.26M19.37%13.11M13.51%3.35M19.72%3.41M23.28%3.37M21.69%2.97M61.19%10.98M-2.99%2.95M116.89%2.85M105.57%2.73M
Deferred tax -86.00%112K231.06%1.21M716.06%6.71M-260.65%-6.3M--0--800K75.13%-924K122.13%822K---1.75M--0
Other non cash items -19.07%1.11M-24.45%4.61M-20.84%1.08M-33.42%1.02M-28.08%1.15M-15.44%1.37M20.30%6.1M-13.00%1.36M15.75%1.53M22.65%1.59M
Change In working capital -127.60%-5.06M-6.35%20.28M-161.79%-9.27M-56.12%5.99M305.27%5.22M511.53%18.34M124.70%21.65M132.85%15.01M143.86%13.64M91.76%-2.54M
-Change in inventory -62.12%8.32M5.03%64.27M-86.24%3.64M-8.77%10.67M-12.49%28M345.94%21.96M148.31%61.19M152.40%26.42M134.58%11.7M195.36%32M
-Change in prepaid assets -111.31%-742K5,639.18%5.57M-32.87%-2.38M86.62%4.23M18.40%-2.84M111.23%6.56M100.98%97K62.61%-1.79M618.31%2.27M20.68%-3.48M
-Change in payables and accrued expense -36.24%-12.66M5.02%-35.71M91.61%-1.35M-10,728.33%-6.38M36.71%-18.68M-216.22%-9.29M-169.13%-37.59M-238.66%-16.13M-98.96%60K-480.43%-29.52M
-Change in other current assets 102.71%24K-37.57%-4.69M-100.39%-20K-573.40%-2.53M18.35%-1.26M86.63%-887K24.90%-3.41M546.35%5.13M85.71%-376K-122.11%-1.54M
-Change in other working capital -----766.79%-9.16M----------------245.29%1.37M------------
Cash from discontinued investing activities
Operating cash flow -88.63%7.28M-24.11%147.66M-79.66%10.52M-45.97%29.93M-1.41%43.15M46.68%64.06M105.80%194.57M793.65%51.74M250.61%55.4M109.61%43.76M
Investing cash flow
Cash flow from continuing investing activities -31.21%-2.78M-434.84%-61.05M-18.39%-10.73M-2,527.66%-46.46M-247.55%-1.74M-19.90%-2.12M60.73%-11.41M22.02%-9.06M82.98%-1.77M119.15%1.18M
Net PPE purchase and sale 12.96%-1.84M61.14%-6.48M89.56%-946K5.09%-1.68M38.59%-1.74M29.71%-2.12M51.24%-16.68M22.02%-9.06M82.98%-1.77M62.62%-2.84M
Net investment purchase and sale ---934K-1,135.96%-54.56M---9.79M---44.78M--0--02.37%5.27M--0--0182.25%4.02M
Cash from discontinued investing activities
Investing cash flow -31.21%-2.78M-434.84%-61.05M-18.39%-10.73M-2,527.66%-46.46M-247.55%-1.74M-19.90%-2.12M60.73%-11.41M22.02%-9.06M82.98%-1.77M119.15%1.18M
Financing cash flow
Cash flow from continuing financing activities 94.24%-1.49M60.02%-79.79M26.41%-17.91M59.75%-18.15M82.52%-17.84M7.91%-25.9M-59.50%-199.58M22.10%-24.33M-5.03%-45.11M-255.02%-102.03M
Net common stock issuance 88.05%-817K94.56%-6.96M99.84%-10K-340.00%-110K100.00%-2K40.33%-6.84M-106.10%-127.96M54.93%-6.41M99.90%-25K-798.07%-110.07M
Cash dividends paid 96.29%-710K-1.95%-73.02M-0.31%-17.98M0.21%-18.04M5.93%-17.83M-15.02%-19.16M-12.16%-71.62M-5.36%-17.92M-7.95%-18.08M-13.49%-18.96M
Proceeds from stock option exercised by employees -65.71%36K--188K--83K--0--0--105K--0--0--0--0
Cash from discontinued financing activities
Financing cash flow 94.24%-1.49M60.02%-79.79M26.41%-17.91M59.75%-18.15M82.52%-17.84M7.91%-25.9M-59.50%-199.58M22.10%-24.33M-5.03%-45.11M-255.02%-102.03M
Net cash flow
Beginning cash position 7.70%94.44M-15.83%87.69M61.74%112.75M141.37%147.41M4.87%123.75M-15.83%87.69M-36.37%104.18M-54.88%69.71M-68.19%61.07M-42.73%118M
Current changes in cash -91.63%3.02M141.53%6.82M-198.75%-18.11M-506.95%-34.68M141.29%23.57M161.41%36.05M72.47%-16.43M136.46%18.34M122.70%8.52M-306.76%-57.08M
Effect of exchange rate changes 66.67%15K-7.46%-72K45.73%-197K-78.15%26K-38.78%90K-70.00%9K-159.82%-67K-1,916.67%-363K88.89%119K1,436.36%147K
End cash Position -21.23%97.47M7.70%94.44M7.70%94.44M61.74%112.75M141.37%147.41M4.87%123.75M-15.83%87.69M-15.83%87.69M-54.88%69.71M-68.19%61.07M
Free cash flow -91.22%5.44M-20.64%141.17M-77.56%9.58M-47.32%28.25M1.17%41.4M52.33%61.94M194.83%177.89M323.63%42.68M891.09%53.63M208.15%40.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg